Predictions
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€9.52
27.05.21
27.05.21
€32.00
27.05.22
27.05.22
-55.61%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Antibe Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.48
08.07.21
08.07.21
-
08.07.22
08.07.22
-80.56%
21.05.22
21.05.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.70
18.04.22
18.04.22
-
18.04.23
18.04.23
-3.95%
30.04.22
30.04.22
Could be very worthwhile Investment >20% year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.96
07.03.22
07.03.22
-
07.03.23
07.03.23
27.52%
28.03.22
28.03.22
Could be worthwhile Investment >10% per year
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
20.02.22
20.02.22
€13.00
20.02.23
20.02.23
-
17.03.22
17.03.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€13.28
12.03.21
12.03.21
€24.00
12.03.22
12.03.22
-62.26%
12.03.22
12.03.22
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.85
20.02.22
20.02.22
-
20.02.23
20.02.23
-14.37%
05.03.22
05.03.22
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€16.47
19.03.21
19.03.21
€13.00
19.03.22
19.03.22
-22.87%
20.02.22
20.02.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.02
16.02.22
16.02.22
-
16.02.23
16.02.23
-10.26%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€7.83
09.02.22
09.02.22
-
09.02.23
09.02.23
-12.11%
18.02.22
18.02.22
Probably not worthwhile Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€36.00
07.02.21
07.02.21
-
07.02.22
07.02.22
-80.67%
08.02.22
08.02.22
Probably not worthwhile Investment
High risks for its business
Few uniques
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.52
23.01.22
23.01.22
-
23.01.23
23.01.23
7.06%
06.02.22
06.02.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
23.01.22
23.01.22
-
23.01.23
23.01.23
15.82%
06.02.22
06.02.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.43
23.01.22
23.01.22
-
23.01.23
23.01.23
7.21%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.62
14.01.22
14.01.22
-
14.01.23
14.01.23
-12.67%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.20
18.09.21
18.09.21
€40.00
31.12.23
31.12.23
61.97%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€4.95
10.10.21
10.10.21
€8.00
31.12.23
31.12.23
58.11%
13.12.21
13.12.21
Could be very worthwhile Investment >20% year
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€4.62
02.12.21
02.12.21
-
02.12.22
02.12.22
45.82%
12.12.21
12.12.21
Risky Investment
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.22
29.11.21
29.11.21
-
29.11.22
29.11.22
-16.11%
12.12.21
12.12.21
Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.25
30.11.21
30.11.21
-
30.11.22
30.11.22
-17.83%
12.12.21
12.12.21
Probably not worthwhile Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.00
28.11.21
28.11.21
-
28.11.22
28.11.22
7.65%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.96
01.12.21
01.12.21
€6.00
01.12.22
01.12.22
-2.70%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
05.10.21
05.10.21
-
05.10.22
05.10.22
-10.00%
08.12.21
08.12.21
Probably not worthwhile Investment